THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

ModeX pipeline progress, 4Kscore reimbursement catalysts, Q2 revenue guidance, cash/buybacks—read key takeaways.

BOSTON and SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced that Vida Health, a leader in virtual cardiometabolic care, is now part of ...

Lexeo Therapeutics, Inc. announced a private placement financing that aims to raise approximately $80 million through the sale of over 20 million shares of its common stock and pre-funded warrants.

In this interview, News Medical speaks with the Healthcare Business of LexisNexis® Risk Solutions about optimizing clinical trial screening and digital health programs through a better understanding ...

AB Science has received a binding offer for a Clinical Trial Funding Insurance policy from Medical & Commercial International Ltd. (MCI), Lloyd’s Syndicate 1902, for its Phase III clinical trial ...

Amwell, a digital care company that connects providers, payers and patients, announced that Hello Heart, a company focused on cardiac health management, has become a partner in its clinical programs ...

Company advances second phase of clinical program for 510(k) submission with method comparison, usability, and interference testing NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio ...

The study was unlikely to meet its primary endpoint based on overall efficacy and safety results from a pre-planned futility analysis. BeiGene has made the decision to end the clinical development ...